Document Detail

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

 Full Text Journal Information Journal ID (nlm-ta): J Nucl Cardiol Journal ID (iso-abbrev): J Nucl Cardiol ISSN: 1071-3581 ISSN: 1532-6551 Publisher: Springer-Verlag, New York Article Information Download PDF © The Author(s) 2012 Received Day: 5 Month: 4 Year: 2011 Accepted Day: 12 Month: 1 Year: 2012 Electronic publication date: Day: 8 Month: 2 Year: 2012 pmc-release publication date: Day: 8 Month: 2 Year: 2012 Print publication date: Month: 6 Year: 2012 Volume: 19 Issue: 3 First Page: 524 Last Page: 533 ID: 3358554 PubMed Id: 22314554 Publisher Id: 9522 DOI: 10.1007/s12350-012-9522-0
 Effects of patient movement on measurements of myocardial blood flow and viability in resting 15O-water PET studies Kazuhiro Koshino, PhD1 Address: +81-6-6833-5012 +81-6-6831-7776 +81-6-6835-5429 koshino@ri.ncvc.go.jp Hiroshi Watabe, PhD2 Junichiro Enmi, PhD1 Yoshiyuki Hirano, PhD1 Tsutomu Zeniya, PhD1 Shinji Hasegawa, MD3 Takuya Hayashi, MD4 Shigeru Miyagawa, MD5 Yoshiki Sawa, MD5 Jun Hatazawa, MD2 Hidehiro Iida, DSc1 1Department of Investigative Radiology, National Cerebral and Cardiovascular Center Research Institute, 5-7-1 Fujishirodai, Suita, Osaka, 565-8565 Japan 2Department of Molecular Imaging in Medicine, Osaka University Graduate School of Medicine, Osaka, Japan 3Department of Cardiology, Osaka Koseinenkin Hospital, Osaka, Japan 4Functional Probe Research Laboratory, RIKEN Center for Molecular Imaging Science, Hyogo, Japan 5Department of Cardiovascular Surgery, Osaka University Graduate School of Medicine, Osaka, Japan

Introduction

Positron emission tomography (PET) has been extensively utilized for a wide range of non-invasive functional imaging of the myocardium in vivo. When using this method, the global body movements of patients could be a source of quantitative errors. Such movement could be particularly problematic when scans are carried out for a relatively long period.1,2 Problems also arise when studies are carried out during physiologically stressed conditions, e.g., a cycling exercise in the PET scanner.3 Errors can be attributed not only to the mismatch between the emission and the transmission data but also to the patient motion during each of the emission and/or the transmission scans.3

15O-water PET studies provide quantitative information regarding myocardial blood flow (MBF) and coronary flow reserve (CFR), as well as a marker of myocardial viability, termed the water perfusable tissue fraction (PTF) or water perfusable tissue index (PTI).4-12 The distribution of radioactivity during 15O-water PET varies over time; this poses challenges for software-based correction of patient movement. Naum et al proposed to correct for such motion based on the rigid body model by aligning two external radioactive markers on the back of each subject. This study was conducted by performing dynamic scans while the subjects were under resting conditions and engaged in a cycling exercise.3 Although no correction was made for the misalignment between transmission and emission scans, their study demonstrated reasonable improvement in calculated MBF values.

In our previous work, we developed an alternative system that uses an optical motion-tracking device to detect and correct for the patient’s global movement during a cardiac 15O-water PET study.13 Our system provides a correction for movement during dynamic scanning, as well as for misalignment between the transmission and the emission scans, to compensate for errors in attenuation correction procedures. We evaluated and methodologically validated the inherent accuracy of this system in a cardiac phantom study. The correction for simulated global movement in a 15O-water cardiac PET study of a healthy volunteer has also demonstrated reasonable regional MBF values, compared to values not adjusted for movement.

The purpose of this study was to evaluate the effects of global movements of subjects on quantification of MBF and PTF. Our previously validated system was used to detect and correct for the global movements of healthy volunteers, as well as patients who have suffered from severe cardiac dysfunction, during 15O-water PET studies under resting conditions.

Methods
Subjects

Subjects consisted of 10 healthy volunteers and 3 patients with previous myocardial infarction. The volunteers were all male, 22-32 years of age (mean ± 1standard deviation (SD) 25 ± 3 years). The volunteers had no signs or symptoms of ischemic heart disease. Patients were studied before and after the cell transplantation therapy with autologous myoblast sheets (AMS).14,15 Scans were carried out by independent clinical research project, but were included in this study by mutual agreement. Two of the patients were male, the other was female; patients were 43-63 years of age. All patients had left ventricular assist systems (LVASs) at the time of PET study, except for one patient who received LVAS after the first PET and before the second PET studies. The PET studies were carried out 67-104 days (mean ± SD 82 ± 19 days) after the implantation of LVASs, and 26-106 days (mean ± SD 56 ± 44 days) after AMS transplantation therapy. All subjects gave written informed consent according to a protocol approved by the Ethical Committee and Internal Review Board of Osaka University.

PET Scan

The PET scanner was a HEADTOME-V tomograph (SHIMADZU Corp., Kyoto, Japan).16 All data were acquired in 2D mode. Reconstructed images were obtained using a filtered back-projection algorithm with a Gaussian filter of 9 mm (full width at half maximum). The matrix and voxel sizes of reconstructed image were 128 × 128 × 63 and 2.03 × 2.03 × 3.13 mm3, respectively. No scatter correction was applied to the image reconstruction.

Each subject was laid on the bed of the PET camera without any fixation of the body, and scanned at rest. A transmission scan was carried out first for correction of photon attenuation (20 minutes on the healthy volunteers, 10-15 minutes on the patients). A 15O-CO emission scan for blood pool imaging was initiated 8 minutes after inhalation of 15O-CO gas for 2 minutes (3.0-3.2 GBq). The 15O-water dynamic emission scan was then carried out following intravenous administration of 15O-water (1.1 GBq over 40 seconds) into the brachial vein, except for one patient who received the administration via right femoral vein. 15O-water scans were performed for 6 minutes, using 26 dynamic frames consisting of 12 × 5 s, 8 × 15 s, and 6 × 30 s. 15O-water scans were performed only once on eight healthy volunteers; two of the volunteers underwent 15O-water scans twice. Thus, a total of twelve 15O-water scans were carried out on the healthy volunteers. One patient underwent PET scans three times (before and after the implantation of LVAS, and after the cell transplantation therapy); the other two were scanned twice (before and after the cell transplantation therapy). Thus, a total of seven PET studies were carried out on the patients.

Motion Detection and Correction

Subject motion during cardiac 15O-water PET was detected using an optical motion-tracking device, POLARIS (Northern Digital Inc., Canada). This method for motion correction (MC) is based on a rigid body model, and performed on each sinogram of the dynamic frame to correct for inter-scan (IS) and inter-frame (IF) motions, as shown in Figure 1. The correction process was performed automatically, based on user input consisting of subject locations measured by POLARIS, sinograms, and reconstruction parameters. In this manuscript, the IS motion denotes global motion between transmission and the first frame of 15O-water emission scan; the IF motion, which is in addition to the IS motion, denotes global motion between frames of the 15O-water scan. Methodological details regarding detection and correction of the motions are described in our previous studies.13,17,18

Motion Classification

Global movement during 15O-water scan was characterized as consisting of IS and IF motions. Accordingly, motion was classified as: (1) IS + IF, in which both IS and IF motions were present; (2) IS motion only; (3) IF motion only; and (4) neither type of movement was present (NE). The presence of each IS and IF motion was determined as described below. Using values [\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$t_{x} (i),\;t_{y} (i),$$\end{document}] and [\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$t_{z} (i)$$\end{document}] to represent translational movement in the x, y, and z, respectively, directions between the transmission and the ith frame of the 15O-water scans, IS motion was considered significant if [\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\sqrt {t_{x} (1)^{2} + t_{y} (1)^{2} + t_{z} (1)^{2} } > 4.0\,{\text{mm}},$$\end{document}] where the value of 4.0 mm was the intrinsic spatial resolution of the PET scanner.16

IF motion was considered to be significant if [\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\mathop {\max }\limits_{i} \left\{ {L(i),H(i)} \right\} > 4.0\,{\text{mm}},$$\end{document}] where L(i) represents the gradual movement of the subject during the scan, and H(i) denotes the motion between adjacent frames. These two components of the IF motion can be expressed as

[Formula ID: Equ1]
1a  [\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$L(i) = \sqrt {\sum\limits_{w = x,y,z} {\left[ {t_{w} (i) - t_{w} (1)} \right]^{2} } }$$\end{document}]
[Formula ID: Equ2]
1b  [\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$H(i) = \sqrt {\sum\limits_{w = x,y,z} {\left[ {t_{w} (i) - t_{w} (i - 1)} \right]^{2} } }$$\end{document}]

Motion Effect Evaluation

To evaluate motion effects on perfusion and viability measurements, we estimated regional MBF and PTF values for nine myocardial segments (anterior, lateral, posterior, and septal wall regions at middle and basal levels, as well as apex) with and without MCs, as described in the following section. Percent differences in the estimated values between with and without MCs for the nine myocardial regions were statistically tested using a one-way ANOVA to find myocardial segments sensitive to global movement. The percent differences were employed owing to avoiding difference of physiological states cross the subjects. The percent difference was defined by [\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\% \Updelta q(i) = 100 \times {{\left| {q_{\text{W}} (i) - q_{\text{WO}} (i)} \right|} \mathord{\left/ {\vphantom {{\left| {q_{\text{W}} (i) - q_{\text{WO}} (i)} \right|} {q_{\text{WO}} (i)}}} \right. \kern-\nulldelimiterspace} {q_{\text{WO}} (i)}},$$\end{document}] where qW(i) and qWO(i) are MBF or PTF values, respectively, for the ith myocardial segment with and without MCs. Absolute values of MBF and PTF with and without MCs for each group were also assessed using Bland-Altman analysis and a paired 2-tailed t test. In the IS + IF motion group, to assess the effects of IS and IF motions, additional MBF and PTF estimations were performed on the data from 15O-water images corrected for IS motions (IS + IF − IS) and also on data corrected for IF motions (IS + IF − IF). The quantitative values obtained from IS + IF − IS data were considered to be affected by IF motion; likewise, values obtained from the IS + IF − IF data were considered to be affected by IS motion. The estimated values were compared to those without MCs using a paired 2-tailed t test. P values <.05 were considered statistically significant. Data was expressed as mean ± 1SD.

MBF and PTF Estimation

Regional MBF and PTF were obtained using the single tissue compartment model with correction for partial volume effects and spillover from the left ventricular cavity (LV)

[Formula ID: Equa]
[\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$C(t) = {\text{MBF}} \cdot {\text{PTF}} \cdot C_{\text{a}} (t) \otimes \exp \left( { - \frac{\text{MBF}}{p}t} \right) + V_{\text{a}} \cdot C_{\text{a}} (t)$$\end{document}]
where C(t) represents the segment tissue time-activity curve (TTAC), Ca(t) represents the arterial time-activity curve, p is the partition coefficient of water in the myocardial tissue (0.91 mL/g), and Va is the arterial blood volume and spillover fraction from LV.19 TTACs were generated for the nine myocardial segments using regions of interest (ROIs) selected within each 15O-water myocardial image with and without MCs. The myocardial image was obtained by subtraction of the early phase of the dynamic 15O-water image from the later phase. The midpoint between two phases was determined for each 15O-water image using the contrast between myocardial regions and LV cavities. To obtain Ca(t), a ROI was first drawn on a motion-corrected 15O-CO image, without regard to whether MC had been applied to the 15O-water image. The recovery coefficient of the LV was calculated from the ROI count on the 15O-CO image and the blood radioactivity concentration. Second, the ROI was transformed to the 15O-water image coordinate using a motion matrix that represents misalignment between transmission and the first dynamic frame of the 15O-water scans. This transformation was made to evaluate motion effects on the 15O-water scan, excluding effects of misalignment between 15O-CO and 15O-water scans. Using the transformed ROI, the LV TAC of the 15O-water image was calculated. Finally, Ca(t) was derived using the LV TAC and the overall TTAC was generated from nine myocardial segments according to the previous method.6 To demonstrate the influence of IS motion, the ROI-based approach was not used; instead, pixel-by-pixel MBF and PTF values were estimated for a representative normal scan.20 To denoise and smooth these parametric images, MBF and PTF were set to zero in voxels with PTF < 0.3 g/mL or Va > 0.8 mL/mL, and then filtered using a Gaussian filter of 14 mm (full width at half maximum).21 For normal scans in the group, improvement of homogeneity between myocardial segments by MC was also evaluated as [\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$100 \times (1 - {\text{SD}}_{\text{W}} /{\text{SD}}_{\text{WO}} ),$$\end{document}] where SDW and SDWO were standard deviations of regional values with and without MCs, respectively.

Results

Table 1 shows global movement during 15O-water scans, categorized by the presence of IS and IF motions. Thirteen scans (7 scans on healthy volunteers and 6 scans on patients) exhibited IS motions greater than 4.0 mm, and 10 scans (5 scans on healthy volunteers and 5 scans on patients) exhibited IF motions greater than 4.0 mm. Among these, 4 scans on healthy volunteers and 5 scans on patients showed both IS and IF motions.

There was no statistically significant difference between the ROI volumes of 15O-water images with and without MCs for IS, IF, and NE motion groups by paired 2-tailed t tests, and between the volumes with and without MCs, IS + IF − IS, and IS + IF − IF motion for IS + IF motion group by a one-way ANOVA.

Table 2 lists MBF and PTF values with and without MCs categorized by the four types of movement that occurred during 15O-water studies, and average percent differences of MBF and PTF values over nine segments. Among 171 myocardial segments from all subjects, the fitting program failed to provide physiologically meaningful values in two segments (middle and basal septa for a healthy volunteer, in which IS + IF motion was detected) in the absence of MC. Those data were excluded from subsequent analysis. Among MBF values, significant changes by MCs were found in the IS + IF, IS + IF − IF, and IF motion groups: for IS + IF, from 0.845 ± 0.366 to 0.769 ± 0.319 mL/minute/g (P < .05); for IS + IF − IF, from 0.845 ± 0.366 to 0.780 ± 0.360 mL/minute/g (P < .05); and for IF, from 0.854 ± 0.179 to 1.088 ± 0.154 mL/minute/g (P < .01). PTF values in the IS motion group changed significantly from 0.465 ± 0.118 to 0.504 ± 0.087 g/mL (P < .05). This significant change is also shown in Figures 2 and 3, as differences between PTF values with and without MCs. In Figure 3, a data point indicated an averaged value for each scan.

Figure 4 illustrates the effect of IS motion of 5.0 mm on MBF and PTF of a normal subject from the IS motion group. The polar maps of normal PTF in Figure 4 demonstrate improvement of homogeneity in anterolateral regions by MC. Improvements of homogeneity of three normal scans in the group were 2.6% ± 26.1% for MBF and 30.9% ± 22.7% for PTF.

Relative variability of regional MBF and PTF values due to global motion are shown in Figures 5 and 6, respectively. For MBF and PTF values in each motion group including the IS + IF − IS and IS + IF − IF groups, no significant difference between myocardial segments was observed in a one-way ANOVA (IF motion group was excluded from this analysis because one scan was assigned to this group. Data for IS + IF − IS and IS + IF − IF group were not shown).

Discussion

In this study, global movements of the subjects during 15O-water PET scans at rest were categorized as IS and IF motions. IS motion involves misalignment relative to the transmission scan, whereas IF motions involves changes between the dynamic frames during the 15O-water scan. After categorization, the effects of these motions on MBF and PTF measurements were evaluated. Consequently, it was demonstrated that MBF values are affected by IF motion rather than IS motion.

Investigation of regional sensitivity to global movement resulted in no significant difference in regional MBF or PTF. This is because the direction and the magnitude of global movement varied for each subject; under- and over-estimation of MBF and PTF due to the motion could have occurred in any myocardial region. In this study, we utilized a one-way ANOVA to detect segmental differences. Due to small sample sizes, the ANOVA may fail to detect the differences. Correlation between segmental differences and the directions of global motions, especially IS motion, effects of which have been reported for misregistration between CT attenuation map and emission image,22,23 could be observed in large population study.

MBF values changed significantly upon correction for IF motions in the IF, IS + IF, and IS + IF − IF motion groups. In contrast, correction of IS motion was considered to have little effect, based on the results from the IS + IF − IS and IS motion groups in Table 2. It was further demonstrated that IF motion, but not IS motion, was an important source of error in the MBF measurement. The significant but small changes in MBF of IF, IS + IF, and IS + IF − IF motion groups after MCs could be due to the relatively large number of healthy volunteer scans in each group (1 of 1 scan for IF, 4 of 9 scans for IS + IF, respectively), as shown in Table 1. Suppression of IF motion during the 15O-water scan is needed for accurate MBF measurement. For the IS motion groups, no significant change in MBF values and significant change in PTF values were observed by MCs (Figures 2, 3). For the normal scans in the group, the improvement of regional homogeneity was also observed in PTF rather than MBF. This is because the MBF values obtained using the kinetic model employed in this study were based on a clearance rate assessment of 15O-water rather than the uptake rate of the radiotracer.5 This is consistent with the findings of Lubberink et al,21 who reported that MBF values do not change even if attenuation correction is omitted; this correction only caused changes in the absolute scale of TTAC, which then caused changes in PTF values. IS motions were also detected in the IS + IF motion group. For the IS + IF − IS motion group, in which IS motions were corrected, no significant change in PTF values was observed after MCs. This might be because IS and IF motions affected the 15O-water images not subjected to MC in such a way as to cancel out errors in PTF measurements. PTF values were considered to be more affected than MBF values during the wash-in phase. However, in our study, IF motion had little effect on PTF values for the IS + IF − IF and IF groups, as shown in Table 2. The reasons for this discrepancy are follows: (1) to estimate the quantitative values, a nonlinear least squares method with same weights for all data points were applied to the data corrected for the physical decay. This fitting manner could be sensitive to radioactivity concentration in wash-out phase rather than wash-in phase. (2) Over-estimation in TTAC was introduced by contamination of the LV cavity count, using the ROI for TTAC superimposed on dynamic frames. However, the spillover correction could suppress the influence of IF motion. One of the advantages of 15O-water over other cardiac PET tracers is that perfusion and viability measurements can be obtained from a single PET scan with short duration. Because accurate PTF measurement enabled assessment of myocardial viability,7-12 correction of IS motion, the effect of which was shown as the improvement of regional homogeneity of normal PTF in Figure 4, is considered to be important in the diagnosis of myocardial infarction, or evaluation of effects of cell transplantation therapies.

In this study, we performed 15O-CO scans to determine a recovery coefficient for each subject.5,615O-water PET studies without 15O-CO scans have been reported in previous papers3,21,24; in these studies, the recovery coefficient could be fixed, or assumed to have a constant value. Omission of the 15O-CO scan shortened the examination time, and might reduce motion artefacts. However, we considered that the adequacy of using a fixed recovery coefficient is still an unresolved issue in 15O-water PET. We considered that the changes in MBF and PTF resulting from MCs were due to correction for global motion, and not due to variability of myocardial tissue ROIs drawn manually on 15O-water images. We employed nine segmented regions rather than 17-segment AHA standard model for suppressing relatively large noise level of 15O-water data.4 In addition, the volumes of the ROIs for each motion group before and after MCs were almost equal (not statistically significant). Furthermore, lower sensitivity of MBF values to variation in ROI size and shape was demonstrated by Iida et al.4 In this study, global motion might have occurred because subjects were scanned without any fixation. Although tight fixation prevents patient motion, such fixation could bring discomfort or pain to the patient; subsequent reaction to such pain could itself induce motion.

One limitation of this study is that all subjects were scanned at rest. When pharmacological or physiological stressors are administered, motion artefacts could be induced, as shown by Naum et al3 in the context of physiological stress conditions. Our finding that MBF was sensitive to IF motion rather than IS motion was considered to be valid for a stress study; IF motion might be source of severe error in MBF and CFR measurements. The rigid body model, which was used in this study, has been promoted for motion compensation not only in brain PET but also in cardiac PET. McCord et al1 employed the rigid body model to correct for misalignment during the transmission and 18F-fluorodeoxyglucose (18F-FDG) emission scans. Bacharach et al2 also proposed a registration technique based on the rigid body model for 18F-FDG emission images acquired on different days. The use of the rigid body model is considered to be valid for non-gated cardiac PET images because the images were smoothed spatially due to cardiac wall motion, and also averaged temporally over the duration of the dynamic frames. However, in stress studies, over-correction due to relatively large respiratory motions might be introduced by our system because the subject’s motion was estimated by measurement of the location of a target attached on the thoracic surface. With this in mind, further work is necessary to evaluate the contribution of MC in combination with a respiratory gating technique.

The MC system was applied to clinical follow-up studies of the patients who received LVAS and cell transplantation therapy. The aim of this study was to investigate the effects of global movement on quantification of MBF and PTF values in a single 15O-water PET study under resting conditions. Although, we believed that the MC system could contribute to an accurate evaluation of regional perfusion and viability, the effects of LVAS implantation and AMS transplantation therapy on those patients is beyond the scope of the present study, and will be studied elsewhere.

Conclusions

This study demonstrated that IF motion during 15O-water scans under resting conditions could be the source of error in MBF measurement. Furthermore, estimated MBF values were less sensitive than PTF values to misalignment between the transmission and the 15O-water emission scans.

Notes

This study was supported by a Research Grant from the New Energy and Industrial Technology Development Organization (NEDO), Japan; a Grant for Translational Research from the Ministry of Health, Labour and Welfare (MHLW) of Japan; a Grant for Advanced Medical Technology from the Ministry of Health, Labour and Welfare (MHLW) of Japan; the Program for Promotion of Fundamental Studies in Health Science of the Organization for Pharmaceutical Safety and Research of Japan; and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.

The authors are much indebted to the technical staff of the Department of Radiology, Osaka University Hospital, for their assistance. This study was supported by a Research Grant from the New Energy and Industrial Technology Development Organization (NEDO), Japan; a Grant for Translational Research from the Ministry of Health, Labour and Welfare (MHLW) of Japan; a Grant for Advanced Medical Technology from the Ministry of Health, Labour and Welfare (MHLW) of Japan; the Program for Promotion of Fundamental Studies in Health Science of the Organization for Pharmaceutical Safety and Research of Japan; and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan

Conflicts of interest

The authors have no conflicts of interest to disclose.

Open Access

References
 1.. McCord ME,Bacharach SL,Bonow RO,Dilsizian V,Cuocolo A,Freedman N. Misalignment between PET transmission and emission scans: Its effect on myocardial imagingJ Nucl MedYear: 199233120912141597741 2.. Bacharach SL,Douglas MA,Carson RE,Kalkowski PJ,Freedman NM,Perrone-Filardi P,et al. Three-dimensional registration of cardiac positron emission tomography attenuation scansJ Nucl MedYear: 1993343113218429355 3.. Naum A,Laaksonen MS,Tuunanen H,Oikonen Va,Teräs M,Kemppainen J,et al. Motion detection and correction for dynamic (15)O-water myocardial perfusion PET studiesEur J Nucl Med Mol ImagingYear: 2005321378138310.1007/s00259-005-1846-416142471 4.. Iida H,Kanno I,Takahashi A,Miura S,Murakami M,Takahashi K,et al. Measurement of absolute myocardial blood flow with H215O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effectCirculationYear: 19887810411510.1161/01.CIR.78.1.1043260151 5.. Iida H,Rhodes CG,Silva R,Yamamoto Y,Araujo LI,Maseri A,et al. Myocardial tissue fraction-correction for partial volume effects and measure of tissue viabilityJ Nucl MedYear: 199132216921751941156 6.. Iida H,Rhodes CG,Silva R,Araujo LI,Bloomfield PM,Lammertsma AA,et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomographyJ Nucl MedYear: 199233166916771517842 7.. Yamamoto Y,Silva R,Rhodes CG,Araujo LI,Iida H,Rechavia E,et al. A new strategy for the assessment of viable myocardium and regional myocardial blood flow using 15O-water and dynamic positron emission tomographyCirculationYear: 1992861671781617770 8.. Silva R,Yamamoto Y,Rhodes CG,Iida H,Nihoyannopoulos P,Davies GJ,et al. Preoperative prediction of the outcome of coronary revascularization using positron emission tomographyCirculationYear: 199286173817421451245 9.. Iida H,Rhodes CG,Araujo LI,Yamamoto Y,Silva R,Maseri A,et al. Noninvasive quantification of regional myocardial metabolic rate for oxygen by use of 15O2 inhalation and positron emission tomography. Theory, error analysis, and application in humansCirculationYear: 1996947928078772704 10.. Chareonthaitawee P,Kaufmann PA,Rimoldi O,Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humansCardiovasc ResYear: 20015015116110.1016/S0008-6363(01)00202-411282088 11.. Knaapen P,Boellaard R,Götte MJ,Weerdt AP,Visser CA,Lammertsma AA,et al. The perfusable tissue index: A marker of myocardial viabilityJ Nucl Cardiol.Year: 20031068469110.1016/S1071-3581(03)00656-114668782 12.. Knaapen P,Boellaard R,Götte MJ,Dijkmans PA,Campen LM,Cock CC,et al. Perfusable tissue index as a potential marker of fibrosis in patients with idiopathic dilated cardiomyopathyJ Nucl MedYear: 2004451299130415299052 13.. Koshino K,Watabe H,Hasegawa S,Hayashi T,Hatazawa J,Iida H. Development of motion correction technique for cardiac 15O-water PET study using an optical motion tracking systemAnn Nucl MedYear: 20102411110.1007/s12149-009-0323-819957212 14.. Miyagawa S,Matsumiya G,Funatsu T,Yoshitatsu M,Sekiya N,Fukui S,et al. Combined autologous cellular cardiomyoplasty using skeletal myoblasts and bone marrow cells for human ischemic cardiomyopathy with left ventricular assist system implantation: Report of a caseSurg TodayYear: 20093913313610.1007/s00595-008-3803-x19198991 15.. Miyagawa S,Saito A,Sakaguchi T,Yoshikawa Y,Yamauchi T,Imanishi Y,et al. Impaired myocardium regeneration with skeletal cell sheets—a preclinical trial for tissue-engineered regeneration therapyTransplantationYear: 20109036437210.1097/TP.0b013e3181e6f20120555308 16.. Iida H,Miura S,Kanno I,Ogawa T,Uemura K. Myers R,Cunningham V,Bailey DA new PET camera for noninvasive quantitation of physiological functional parametric images: HEADTOME-V-DualQuantification of brain function using PETYear: 1996LondonAcademic Press5761 17.. Watabe H,Sato N,Kondoh Y,Fulton RR,Iida H. Senda M,Kimura Y,Herscovitch PCorrection of head movement using optical motion tracking system during PET study with rhesus monkeyBrain imaging using PETYear: 2002LondonAcademic Press18 18.. Woo SK,Watabe H,Yong C,Kim KM,Choon C,Bloomfield PM,et al. Sinogram-based motion correction of PET images using optical motion tracking system and list-mode data acquisitionIEEE Trans Nucl SciYear: 20045178278810.1109/TNS.2004.829786 19.. Katoh C,Morita K,Shiga T,Kubo N,Nakada K,Tamaki N,et al. Improvement of algorithm for quantification of regional myocardial blood flow using 15O-water with PETJ Nucl MedYear: 2004451908191615534062 20.. Watabe H,Jino H,Kawachi N,Teramoto N,Hayashi T,Ohta Y,et al. Parametric imaging of myocardial blood flow with 15O-water and PET using the basis function methodJ Nucl MedYear: 2005461219122416000292 21.. Lubberink M,Harms HJ,Halbmeijer R,Haan S,Knaapen P,Lammertsma AA. Low-dose quantitative myocardial blood flow imaging using 15O-water and PET without attenuation correctionJ Nucl MedYear: 20105157558010.2967/jnumed.109.07074820237035 22.. Goetze S,Brown TL,Lavely WC,Zhang Z,Bengel FM. Attenuation correction in myocardial perfusion SPECT/CT: Effects of misregistration and value of reregistrationJ Nucl MedYear: 2007481090109510.2967/jnumed.107.04053517574985 23.. Martinez-Möller A,Souvatzoglou M,Navab N,Schwaiger M,Nekolla SG. Artifacts from misaligned CT in cardiac perfusion PET/CT studies: Frequency, effects, and potential solutionsJ Nucl MedYear: 20074818819317268013 24.. Nesterov SV,Han C,Mäki M,Kajander S,Naum AG,Helenius H,et al. Myocardial perfusion quantitation with 15O-labelled water PET: High reproducibility of the new cardiac analysis software (Carimas)Eur J Nucl Med Mol ImagingYear: 2009361594160210.1007/s00259-009-1143-819408000

Figures
 [Figure ID: Fig1] Figure 1  Schematic diagram of the correction for IS and IF motions [Figure ID: Fig2] Figure 2  Differences between PTF values with and without the motion corrections. IS, Inter-scan motion; IF, inter-frame motion; NE, no significant motion. IS + IF − IS and IS + IF − IF are groups corrected for IS and IF motion in the IS + IF group, respectively [Figure ID: Fig3] Figure 3  Changes in PTF values in the absolute scale by the MCs. IS, Inter-scan motion; IF, inter-frame motion; NE, no significant motion. IS + IF − IS and IS + IF − IF are groups corrected for IS and IF motion in the IS + IF group, respectively. A data point indicates an averaged value for each scan [Figure ID: Fig4] Figure 4  Effect of an IS motion of 5.0 mm on MBF and PTF of a normal subject in IS motion group [Figure ID: Fig5] Figure 5  Relative variability of regional MBF due to effects of global motion. IS, Inter-scan motion; IF, inter-frame motion; NE represents no significant motion. IS + IF − IS and IS + IF − IF are groups corrected for IS and IF motion in the IS + IF group, respectively [Figure ID: Fig6] Figure 6  Relative variability of regional PTF due to effects of global motion. IS, Inter-scan motion; IF, inter-frame motion; NE represents no significant motion. IS + IF − IS and IS + IF − IF are groups corrected for IS and IF motion in the IS + IF group, respectively

Tables
[TableWrap ID: Tab1] Table 1

Characteristics of motion during 15O-water scans

Motion type Total (normal) scans IS motion (mm) IF motion (mm)
IS + IF 9 (4) 7.7 ± 2.7 11.0 ± 4.0
IS 4 (3) 5.4 ± 1.0 2.8 ± 1.1
IF 1 (1) 2.7 5.1
NE 5 (4) 2.5 ± 0.7 1.4 ± 0.5

[TableWrap ID: Tab2] Table 2

The summary of MBF and PTF values with and without MCs

Motion type Without MC With MC Percent difference
MBF (mL/minute/g)
IS + IF 0.845 ± 0.366 0.769 ± 0.319* 33.8 ± 61.5
IS + IF − IS 0.815 ± 0.341 21.2 ± 38.5
IS + IF − IF 0.780 ± 0.360* 25.1 ± 41.4
IS 0.855 ± 0.343 0.828 ± 0.259 9.0 ± 8.9
IF 0.854 ± 0.179 1.088 ± 0.154 30.2 ± 20.9
NE 0.898 ± 0.233 0.909 ± 0.221 9.7 ± 15.7
PTF (g/mL)
IS + IF 0.476 ± 0.133 0.469 ± 0.128 13.9 ± 10.9
IS + IF − IS 0.471 ± 0.135 12.3 ± 13.0
IS + IF − IF 0.490 ± 0.119 12.3 ± 10.2
IS 0.465 ± 0.118 0.504 ± 0.087* 9.0 ± 9.6
IF 0.512 ± 0.067 0.483 ± 0.068 7.1 ± 5.6
NE 0.488 ± 0.095 0.496 ± 0.100 5.1 ± 4.9

IS, Inter-scan; IF, inter-frame.

NE denotes motion ≤4.0 mm. IS + IF − IS and IS + IF − IF represent IS + IF motion groups with correction of IS and IF motions, respectively.

P < .05, † P < .01 vs without MC.

 Article Categories:Original Article Keywords: Keywords Myocardial blood flow, water-perfusable tissue fraction, PET, myocardial perfusion imaging, motion correction, 15O-labeled water.

Previous Document:  Correlation between clinical outcomes and appropriateness grading for referral to myocardial perfusi...
Next Document:  Acute hyperglycemia causes microvascular damage, leading to poor functional recovery and remodeling ...